Relief Therapeutics Holding AG reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CHF 3.02 million compared to CHF 3.24 million a year ago. Revenue was CHF 3.09 million compared to CHF 3.81 million a year ago.

Net loss was CHF 56.5 million compared to CHF 26.5 million a year ago. Basic loss per share from continuing operations was CHF 5.098 compared to CHF 2.551 a year ago. Diluted loss per share from continuing operations was CHF 5.098 compared to CHF 2.551 a year ago.